TRIM22, rarely investigated in most human cancers, regulates biological processes in various cell types through NF-κB signaling, including macrophages [24, 25], neurons [26], and human embryonic kidney 293 T cells (HEK293T) [27, 28]. This evidence concerns the gene NFKB1 and cancer.